Middletown Life

Author: Cambium Biomaterials, Inc

Cambium Begins Transition of Its Counter-Laser and Counter-Directed Energy Technology to Address Larger Form Factors and Threats

March 10, 2026
Cambium Secures $100 Million Series B to Accelerate the Discovery and Scaling of Advanced Materials

January 5, 2026
Cambium Expands Leadership with Appointment of Chris Pederson as Independent Board Director

December 15, 2025
Cambium Receives Contract from DARPA to Leverage AI to Accelerate Discovery of Novel Extreme-Temperature Materials

November 21, 2025